TR201818754T4 - Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri - Google Patents

Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri Download PDF

Info

Publication number
TR201818754T4
TR201818754T4 TR2018/18754T TR201818754T TR201818754T4 TR 201818754 T4 TR201818754 T4 TR 201818754T4 TR 2018/18754 T TR2018/18754 T TR 2018/18754T TR 201818754 T TR201818754 T TR 201818754T TR 201818754 T4 TR201818754 T4 TR 201818754T4
Authority
TR
Turkey
Prior art keywords
brimonidine
preservatives
timolol
solutions
timolol solutions
Prior art date
Application number
TR2018/18754T
Other languages
English (en)
Inventor
LIKITLERSUANG Sukhon
F Kelly William
P Parashar Ajay
P Pujara Chetan
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44504227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201818754(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of TR201818754T4 publication Critical patent/TR201818754T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş intraoküler basıncı düşürme ve glokom tedavisi için koruyucu içermeyen brimonidin ve timolol çözeltilerine yöneliktir.
TR2018/18754T 2010-07-29 2011-07-28 Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri TR201818754T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36868110P 2010-07-29 2010-07-29

Publications (1)

Publication Number Publication Date
TR201818754T4 true TR201818754T4 (tr) 2019-01-21

Family

ID=44504227

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18754T TR201818754T4 (tr) 2010-07-29 2011-07-28 Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri

Country Status (12)

Country Link
US (3) US10213431B2 (tr)
EP (2) EP2598119B1 (tr)
AU (1) AU2011282683B2 (tr)
CA (1) CA2807084C (tr)
DK (1) DK2598119T3 (tr)
ES (1) ES2709180T3 (tr)
HU (1) HUE040283T2 (tr)
PL (1) PL2598119T3 (tr)
PT (1) PT2598119T (tr)
SI (1) SI2598119T1 (tr)
TR (1) TR201818754T4 (tr)
WO (1) WO2012016000A2 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
GR1008330B (el) * 2013-10-17 2014-10-20 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
AU2016233125A1 (en) * 2015-03-19 2017-09-14 Allergan, Inc. Fixed dose combination of bromonidine and timolol
JP2017002035A (ja) * 2015-06-05 2017-01-05 参天製薬株式会社 ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤
US11541018B2 (en) * 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
JP7251033B2 (ja) 2016-07-27 2023-04-04 コリウム， エルエルシー ドネペジル経皮送達システム
AU2018392686A1 (en) 2017-12-20 2020-07-09 Corium Pharma Solutions, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
GR1010024B (el) * 2020-05-06 2021-06-01 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση που περιλαμβανει βριμονιδινη

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795970A (fr) 1972-02-29 1973-08-27 Pfizer Nouveaux derives de quinoleine, quinoxaline et quinazoline er composition pharmaceutiques les contenant
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
CA1334168C (en) 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US5021416A (en) 1989-10-31 1991-06-04 Allergan, Inc. Method for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressure
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
CA2536061A1 (en) * 2003-08-22 2005-03-17 Edward J. Ellis Polymeric systems for controlled drug therapy
WO2008024846A2 (en) * 2006-08-25 2008-02-28 Allergan, Inc. Brimonidine and timolol compositions
MX2007010025A (es) * 2007-08-17 2009-02-25 Arturo Jimenez Bayardo Composición farmacéutica para tratamiento de hipertensión ocular.
PE20160904A1 (es) 2009-12-22 2016-09-16 Allergan Inc Combinacion triple para reduccion de presion intraocular

Also Published As

Publication number Publication date
WO2012016000A2 (en) 2012-02-02
AU2011282683A1 (en) 2013-03-07
PL2598119T3 (pl) 2019-03-29
ES2709180T3 (es) 2019-04-15
US10213431B2 (en) 2019-02-26
EP2598119B1 (en) 2018-09-19
US20140148456A1 (en) 2014-05-29
CA2807084A1 (en) 2012-02-02
PT2598119T (pt) 2018-12-17
EP2598119A2 (en) 2013-06-05
WO2012016000A3 (en) 2012-03-15
US20210228587A1 (en) 2021-07-29
SI2598119T1 (sl) 2019-02-28
EP3434257A1 (en) 2019-01-30
DK2598119T3 (en) 2019-01-07
US20190307759A1 (en) 2019-10-10
US10792288B2 (en) 2020-10-06
CA2807084C (en) 2018-05-22
AU2011282683B2 (en) 2016-12-22
HUE040283T2 (hu) 2019-02-28

Similar Documents

Publication Publication Date Title
TR201818754T4 (tr) Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri
MX2014000781A (es) Dosis combinada fija de bimatoprost y brimonidina.
WO2012015998A3 (en) Preservative free bimatoprost and timolol solutions
IN2015DN01156A (tr)
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
MX351464B (es) El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
UA114705C2 (uk) Андрогенна композиція для лікування офтальмологічного захворювання
EA201500362A1 (ru) Ингибиторы rho-киназы
MY171920A (en) Prevention and treatment of ocular conditions
TR201905683T4 (tr) Aşındırıcı presbiyopi için oftalmik formülasyon ve yöntem.
EA201891833A1 (ru) Комбинация для лечения амиотрофического бокового склероза или родственных болезней
TR201820663T4 (tr) İntrakameral bimatoprost implantları ile intraoküler basıncın düşürülmesi.
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
EA201390198A1 (ru) Гетероциклическое соединение
EA201171339A1 (ru) Способ снижения внутриглазного давления у людей
MX2013001204A (es) Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
EA201590301A1 (ru) Композиции и способы уменьшения содержания алкоголя в крови
EA201490423A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА
EA201491854A1 (ru) Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
MY178905A (en) Prevention, treatment and diagnosis of p.gingivalis infection
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
EA201490721A1 (ru) Лекарственное средство для лечения заболеваний передней камеры глаза, включающее ребамипид и агент, удерживающий слезы
WO2012015996A3 (en) Preservative free bimatoprost solutions
EA201301332A1 (ru) ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α
MY160383A (en) Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension